Tectonic Therapeutic Insider Trades
NASDAQ: TECXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 3 · $235.16K
- Sales
- 11 · $651.01K
- Shares bought / sold
- 11.00K / 22.42K
- Net activity
- Net selling $415,847
Tectonic Therapeutic insider activity
Over the last 12 months, Tectonic Therapeutic insiders reported 37 transactions on SEC Form 4: 3 open-market purchases and 11 sales. Insiders bought $235,160 and sold $651,007 worth of stock, for net insider selling of $415,847. The largest seller was Ruddy Marcella K., with $363,000 in reported sales.
The most recent filing shows McNamara Peter (Chief Scientific Officer) selling 536 shares at $23.04 on Sep 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TECX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
TECX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 30, 2026 | McNamara PeterChief Scientific Officer | Sale | 536 | $12.35K | Form 4 |
| Sep 25, 2026 | Schwabish MarcChief Business Officer | Tax withholding | 411 | $9.73K | Form 4 |
| Sep 25, 2026 | Lochner DanielChief Financial Officer | Tax withholding | 520 | $12.31K | Form 4 |
| Sep 25, 2026 | REICIN ALISEChief Executive Officer | Tax withholding | 1,545 | $36.57K | Form 4 |
| Sep 25, 2026 | Ruddy Marcella K.Chief Medical Officer | Tax withholding | 525 | $12.43K | Form 4 |
| Sep 25, 2026 | McNamara PeterChief Scientific Officer | Tax withholding | 444 | $10.51K | Form 4 |
| Aug 25, 2026 | McNamara PeterChief Scientific Officer | Sale | 43 | $1.57K | Form 4 |
| Aug 25, 2026 | McNamara PeterChief Scientific Officer | Option exercise | 43 | $632.53 | Form 4 |
| Aug 12, 2026 | McNamara PeterChief Scientific Officer | Sale | 43 | $1.50K | Form 4 |
| Aug 12, 2026 | McNamara PeterChief Scientific Officer | Option exercise | 43 | $632.53 | Form 4 |
| Jun 30, 2026 | McNamara PeterChief Scientific Officer | Sale | 172 | $6.02K | Form 4 |
| Jun 30, 2026 | McNamara PeterChief Scientific Officer | Option exercise | 172 | $2.53K | Form 4 |
| Jun 20, 2026 | REICIN ALISEChief Executive Officer | Tax withholding | 924 | $28.03K | Form 4 |
| May 4, 2026 | Ruddy Marcella K.Chief Medical Officer | Sale | 1,065 | $31.95K | Form 4 |
| Apr 1, 2026 | Ruddy Marcella K.Chief Medical Officer | Sale | 1,000 | $31.05K | Form 4 |
| Mar 6, 2026 | McNamara PeterChief Scientific Officer | Sale | 215 | $7.53K | Form 4 |
| Mar 6, 2026 | McNamara PeterChief Scientific Officer | Sale | 6,047 | $181.41K | Form 4 |
| Mar 6, 2026 | McNamara PeterChief Scientific Officer | Option exercise | 215 | $3.16K | Form 4 |
| Mar 6, 2026 | McNamara PeterChief Scientific Officer | Option exercise | 2,500 | $5.95K | Form 4 |
| Mar 6, 2026 | Ruddy Marcella K.Chief Medical Officer | Sale | 10,000 | $300.00K | Form 4 |
| Mar 4, 2026 | Lochner DanielChief Financial Officer | Award | 26,500 | — | Form 4 |
| Mar 4, 2026 | McNamara PeterChief Scientific Officer | Sale | 1,650 | $41.25K | Form 4 |
| Mar 4, 2026 | McNamara PeterChief Scientific Officer | Award | 23,000 | — | Form 4 |
| Mar 4, 2026 | Schwabish MarcChief Business Officer | Award | 19,500 | — | Form 4 |
| Mar 4, 2026 | Ruddy Marcella K.Chief Medical Officer | Award | 26,500 | — | Form 4 |
| Mar 4, 2026 | REICIN ALISEChief Executive Officer | Award | 76,500 | — | Form 4 |
| Mar 3, 2026 | McNamara PeterChief Scientific Officer | Sale | 1,649 | $36.38K | Form 4 |
| Feb 11, 2026 | REICIN ALISEChief Executive Officer | Buy | 2,500 | $52.75K | Form 4 |
| Feb 11, 2026 | REICIN ALISEChief Executive Officer | Buy | 2,500 | $52.75K | Form 4 |
| Feb 10, 2026 | Lochner DanielChief Financial Officer | Buy | 6,000 | $129.66K | Form 4 |
| Feb 10, 2026 | Schwabish MarcChief Business Officer | Option exercise | 4,500 | $10.71K | Form 4 |
| Feb 4, 2026 | Lochner DanielChief Financial Officer | Tax withholding | 2,077 | $48.23K | Form 4 |
| Feb 4, 2026 | McNamara PeterChief Scientific Officer | Tax withholding | 1,748 | $40.59K | Form 4 |
| Feb 4, 2026 | REICIN ALISEChief Executive Officer | Tax withholding | 4,104 | $95.29K | Form 4 |
| Feb 4, 2026 | Ruddy Marcella K.Chief Medical Officer | Tax withholding | 2,064 | $47.93K | Form 4 |
| Feb 4, 2026 | Schwabish MarcChief Business Officer | Tax withholding | 1,619 | $37.59K | Form 4 |
| Dec 31, 2025 | REICIN ALISEChief Executive Officer | Option exercise | 10,966 | $26.10K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4